Procter & Gamble Health Ltd PGHL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹5,464.50
- Day Range
- ₹5,436.50–5,540.00
- 52-Week Range
- ₹4,707.00–6,975.00
- Bid/Ask
- ₹5,452.50 / ₹5,457.50
- Shares Outstanding
- 16.60M
- Market Cap
- ₹90.52B
- Volume/Avg
- 865 / 12,304
Key Statistics
- Price/Earnings (Normalized)
- 23.56
- Price/Sales
- 6.64
- Dividend Yield (Trailing)
- 2.84%
- Dividend Yield (Forward)
- 2.84%
- Dividend Payment Schedule
- Feb, Sep
- Total Yield
- 2.84%
Company Profile
Procter & Gamble Health Ltd is in the business of manufacturing and marketing of pharmaceuticals. It has single primary reportable segment Pharmaceuticals. Majority of revenue comes from India. Its brands are Betamil, Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,500
Valuation
Metric | PGHL |
|---|---|
Price/Earnings (Normalized) | 23.56 |
Price/Book Value | 13.78 |
Price/Sales | 6.64 |
Price/Cash Flow | 26.13 |
Price/Earnings
PGHL
Financial Strength
Metric | PGHL |
|---|---|
Quick Ratio | 1.76 |
Current Ratio | 2.43 |
Interest Coverage | 899.62 |
Quick Ratio
PGHL
Profitability
Metric | PGHL |
|---|---|
Return on Assets (Normalized) | 39.10% |
Return on Equity (Normalized) | 59.83% |
Return on Invested Capital (Normalized) | 58.99% |
Return on Assets
PGHL
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Merck KGaA ADR MKKGY | LOCK|?wY^%S!& | LOCK|q@^? | $72B | |||
| Teva Pharmaceutical Industries Ltd TEVA | LOCK|^k<%TcT | LOCK|fkCN | $49B | |||
| Haleon PLC ADR HLN | LOCK|XhS<WH | LOCK|?B | $40B | |||
| Zoetis Inc Class A ZTS | LOCK|T^q$dfWD | LOCK|pd | $34B | |||
| Viatris Inc VTRS | LOCK|?BkTMkD | LOCK|Hz | $23B | |||
| Elanco Animal Health Inc ELAN | LOCK|rX> | LOCK|kg | $13B | |||
| Dr Reddy's Laboratories Ltd ADR RDY | LOCK|!JL?Nf | LOCK|zQ | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A HIMS | LOCK|<bk@@G | LOCK|&>$ | $4B | |||
| Prestige Consumer Healthcare Inc PBH | LOCK|&l><r# | LOCK|qq$v | $2B | |||
| Perrigo Co PLC PRGO | LOCK|$%kz<^ | LOCK|rCJ | $2B |